Great discussions at this morning’s The PMI (Pharmaceutical Managers' Institute) Stakeholder Breakfast exploring the impact of US policy changes on the Irish economy & pharma industry – key insights from Paul Sweetman , Hazel Aherne- Flynn & Roisin Molloy.Thanks for an informative session!#SalutemInsights

At #SalutemInsights, we track every medicine through the full Irish reimbursement process—from EMA approval to final HSE decision. We're updating our 2024 database - stay tuned for weekly insights on Irish market access—starting next Thursday #MarketAccess #HealthEconomics #HTA

ISPOR published a report titled “Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations: An ISPOR Working Group Report” in this month’s issue of Value in Health. Read here: ow.ly/qNhi50V3wq6 #HEOR #AI #HTA

🚨 New Paper Alert! 🚨 Where are we now with Open-Source Models (OSMs) in Health Economics? Our own Dr. Raymond Henderson & co-authors map the OSM landscape in this ISPOR report. 📖 Read more: bit.ly/MappingtheLand… #SalutemInsights #HealthEconomics #ISPOR #DataTransparency

Shane Ryan IPHA President opening the annual IPHA conference. IPHA have partnered and collaborated with patient organisations, HCPs and Government to ensure Innovative medicines are available to Irish patients #IPHAConference2025 #SalutemInsights

Great day at #IPHAConference2025 and hear of the IPHA priorities inlcuding faster access to medicines, increasing clinical trials, improving Irish competitiveness and a life sciences strategy. Fantastic to connect with other industry leaders! #SalutemInsights #Pharma #IPHA

🔎 #TacticalTrendsThursday Week 2🔎 We’re the only company tracking every medicine through the full Irish reimbursement process. Submission volumes are down 📉, HTAs are becoming more complex 📊 & oncology leads the way 🎗️.#SalutemInsights #MarketAccess #HTA #HealthEconomics

🔎 Tactical Trends Thursday – Week 3 🔎 How critical is the Rapid Review in Irish reimbursement? 📊 % leading to HTA vs. price negotiations ⏳ Avg. completion time in 2025 💡 Market access impact Swipe for insights! #SalutemInsights #MarketAccess #HTA #Pharma #Reimbursement

Delighted to be involved in the PMI Summit again this year. It is always a great day to meet customers and stakeholders in the industry. #saluteminsights #pmi25

Tactical Trends Thursday Wk 5: Fast movers win! 1 in 6 HTA submissions in Ireland were made before EMA approval, speeding up reimbursement. Want to gain the advantage in Irish market access? See the data👇 #HTA #Pharma #SalutemInsights #EUJCA #MarketAccess #HTA #IrishHealthcare

🔎 #TacticalTrendsThursday The HSE Drugs Group is assessing more meds—but delays are growing. ⏳ Avg. 8 months to first meeting 📈 MAPs rising 🚪 Impacts access & strategy #MarketAccess #HTA #HSEDrugsGroup #SalutemInsights

🔎 #TacticalTrendsThursday Week 7: 40 drugs reimbursed in 🇮🇪 in 2024. Avg. timeline: 580 days ⏱️ Faster, yes—but still nearly 2 years to access. Progress is real, but high-need therapies can’t afford to wait. #MarketAccess #HTA #Reimbursement #IrishHealthcare #SalutemInsights

The EU HTA era is here. Join Salutem Insights + partners for a 5-part webinar series on JCA across Europe. Starts May 6 at 16:00. 🗓️ Our MD Sandra Redmond speaks on May 13 (Ireland focus). 🔗 Register here: linkedin.com/feed/update/ur… #EUHTA #HTA #MarketAccess #SalutemInsights

The EU HTA journey continues… Join Sandra Redmond from Salutem Insights on May 13 as she shares Ireland’s perspective on JCA alongside experts from 🇧🇪 🇱🇺 🇳🇴 🇦🇹. 🕓 4pm | Free to attend 🔗 Register: bit.ly/3Z2iJiD #EUHTA #HTA #MarketAccess #SalutemInsights

Last chance to register for today's webinar with our own Sandra Redmond sharing Ireland’s perspective on all things EU HTA alongside experts from 🇧🇪 🇱🇺 🇳🇴🇦🇹 4pm | Free to attend Register here: bit.ly/3Z2iJiD #EUHTA #HTA #MarketAccess #SalutemInsights

📢Our own Dr. Raymond Henderson will present at the R for HTA Workshop on June 6th at Queen’s University Belfast. He’ll explore open-source health economic models, based on an ISPOR SIG review. 🕐 12:20 BST | Register here :bit.ly/R-HTAWorkshop #ISPOR #RforHTA #SalutemInsights

📢 Proud moment! Our Senior HTA Consultant Dr. Raymond Henderson is a co-author on an ISPOR Special Interest Group paper just named an Editor’s Choice for June in Value in Health. Free to access now 👉 bit.ly/ValueinHealthJ… #HTA #ISPOR #SalutemInsights #OpenSourceModelling

#ISPORNews Value in Health announced the publication of a groundbreaking study mapping the landscape of available open source models (OSMs) in health economics & revealing key insights into their distribution, characteristics, & applications. Learn more: ow.ly/EFnb50WaJTX

Now online! 🎥 Dr. Raymond Henderson from #SalutemInsights presented at the #RforHTA 2025 Workshop on open-source health economic models. 📍Queen’s University Belfast ▶️ Watch here: bit.ly/RHRforHTAYouTu… #HTA #OpenSource #ISPOR #HealthEconomics

A look at the Accessus Health Access Briefing Q2. From 🇩🇪 to 🇨🇦, 14 market access experts (incl. Salutem Insights 🇮🇪) share HTA updates from Apr–Jun 2025. 📩 Want the full report? Email [email protected] 🔗 Sign up: bit.ly/AccessusHealth… #HTA #SalutemInsights